The Long War on Cancer
That expectation was raised in part by the PR campaign, complete with ads suggesting we could cure cancer by the bicentennial, that successfully pushed President Nixon to support what came to be called his “War on Cancer.”
Since then, the United States government has spent over 100 billion dollars on research and scientists have learned a great deal about how cancer works. While some drugs do extend life, we’ve also seen numerous new drugs and treatments, like Interferon, bone marrow transplants for breast cancer or Interleukin-2 heralded as “breakthroughs,” only to disappoint or even harm patients over time.
There has been long-term success treating a few types of cancer, including lymphomas and leukemias as well as testicular cancer. Early detection and screening, while controversial for some cancers, has also prevented many deaths from cervical and colorectal cancer. But after all these years, all this money, and all of these drugs, most cancers still kill once they metastacize, and over half a million Americans die from the disease each year. Despite the fact that treatments get the most press coverage, the greatest reductions in cancer mortality rates can be credited to lifestyle changes, like quitting smoking. But as we become more obese, and more sedentary, that progress may prove elusive, too.
More Like This
Working Sick During Covid: What We Learned from Swine Flu
‘Stay home if you’re sick’ is time-tested advice. But not all workers can afford it.
What the Bungled Response to HIV Can Teach Us About Dealing With Covid-19
Politics, public health and a pandemic. What we didn’t learn from HIV.
Why History Urges Caution on Immunity Testing
After past outbreaks, workers with proof of antibodies were in demand. But history urges caution.
Xenophobia in the Age of COVID-19
Scapegoating immigrant groups in times of disease outbreak has a long history.